Refine by
Applications
- Solutions for Endometriosis
- Solutions for Severe but Non-Specific Symptoms
- RNA Technology for Research Fellowship
- RNA Technology for Medical Areas of Focus Research
- RNA Technology for Product Pipeline Research
- RNA Technology for Clinical trials
- Solution for Clinical Trials
- Solution for Access to Investigational Medicines
- Medical diagnostics solutions for inflammatory bowel disease sector
- Medical diagnostics solutions for colorectal cancer sector
- Klarity - Built Therapeutic Platform Technologies for Gastrointestinal Disease
- Klarity - Built Therapeutic Platform Technologies for Neurological Disorders
- Klarity - Built Therapeutic Platform Technologies for Metabolism
Disease Target Equipment & Supplies Near Canada
67 equipment items found
by:Intellia Therapeutics, Inc. based inCambridge, MASSACHUSETTS (USA)
Genome editing is efficient, precise and scalable. CRISPR/Cas9 genome editing can make permanent, precisely targeted changes in patients’ chromosomes and repair the underlying genetic mutation, whereas more traditional gene therapy typically involves introducing a non-permanent copy of a gene into patients’ cells. These attributes of CRISPR/Cas9 provide a significant ...
by:Genome Biologics based inFrankfurt am Main, GERMANY
GENIMAPS® and GENISYST® technology integration facilitates Ai-driven target identification, and direct therapeutic interrogation of RNAi disease targets in vitro (2D and 3D), and in small and large animal models. This coupled workflow enables efficient and accelerated RNAi target discovery and efficacy ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
AD1801 is an innovative project to develop disease modifying treatment of Alzheimer’s disease, targeting Apolipoprotein E (ApoE), a different molecule than those targeted in the projects BAN2401 and BAN2401 ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
It is an artificial intelligence technology that can predict biomarkers, prognostic biomarkers and even the mode of action (MOA) of disease ...
by:Zymeworks Inc based inVancouver, BRITISH COLUMBIA (CANADA)
with a modular suite of proprietary cytotoxins (cell-killing compounds), stable linkers, and conjugation technologies. A broader window of opportunity. Deliver potent cell-killing compounds specifically to diseased target cells with optimal safety and efficacy. ZymeLink™, a next-generation antibody drug conjugate (ADC) platform, is a suite of proprietary ...
Manufactured by:Lumen Bioscience, Inc. based inSeattle, WASHINGTON (USA)
We design and manufacture therapeutics against disease targets that have been inaccessible to the biopharmaceutical industry because of the astonishingly high cost of traditional methods. Now, for the first time, Lumen can make antibodies and other biologics at a cost that allows for daily, high-dose, oral and topical delivery. Our current programs ...
Manufactured by:Roche Diagnostics International AG based inRotkreuz, SWITZERLAND
The XT-8 system is the pioneer of true multiplex molecular testing, offering post-PCR detection for infectious disease, genetics, and pharmacogenetics ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
It specializes in genome data analysis, biomarker prediction, molecule selection and optimization. DEARGEN discovers new disease targets with Dr.UG and further realizes precision medicine by designing small molecules for new ...
Manufactured by:MorphoSys AG based inPlanegg, GERMANY
Peptides are an increasingly important class of drug. As natural ligands to many targets, they can combine agonistic or antagonistic activity with low toxicity risk and can be applied to disease targets, where small molecules or antibody-based drugs cannot be used. However, the number of therapeutic peptide drugs is held back by properties that ...
Manufactured by:Xoft, Inc. based inSan Jose, CALIFORNIA (USA)
The versatile Xoft Axxent® Electronic Brachytherapy (eBx) System utilizes breakthrough electronic brachytherapy technology to provide expanded treatment options for a range of cancers. With the Axxent controller, highly focused therapeutic radiation of the disease target is possible in a minimally shielded setting, while sparing surrounding healthy ...
Manufactured by:Xoft, Inc. based inSan Jose, CALIFORNIA (USA)
The source is placed inside the applicator and energized to deliver a precise, prescribed dose of radiation. With the Xoft System, highly focused therapeutic radiation of the disease target is possible in a minimally shielded setting, while sparing surrounding healthy ...
by:Kephera Diagnostics, LLC based inFramingham, MASSACHUSETTS (USA)
At Kephera, we are developing rapid tests for infectious diseases using novel immunochemistry in point-of-care format. Our proprietary assay technology is based on principles of particle interaction combined with a simple device, which together enable rapid detection of specific antibodies or antigens associated with the target pathogen. The broadly enabling ...
Manufactured by:Xoft, Inc. based inSan Jose, CALIFORNIA (USA)
The versatile Xoft Axxent Electronic Brachytherapy (eBx) System utilizes state-of-the-art 50kV x-ray technology to provide expanded treatment options for a range of cancers. The Xoft System provides isotope-free HDR therapeutic radiation of the disease target while sparing surrounding healthy ...
Manufactured by:NexImmune, Inc. based inGaithersburg, MARYLAND (USA)
The injectable modality (AIM INJ) is an injectable pharmaceutical product of AIM nanoparticles decorated with antigen-specific peptides and co-stimulatory molecules appropriate for the disease being targeted. Based on specific size and bio-distribution characteristics, the AIM™ nanoparticles have the ability to engage antigen-specific T cell populations at ...
Manufactured by:Robocath based inRouen, FRANCE
Innovation is at the heart of Robocath’s strategy, making R-One™ a unique solution, protected by over 60 international ...
Manufactured by:DermBiont, Inc. based inBoston, MASSACHUSETTS (USA)
leverage cutting edge innovation in dermatology and proprietary technology to efficiently develop targeted small molecule therapeutics and novel microbiome-based therapeutics for dermatologic indications that address the root cause of skin diseases. Our in-house discovery platform for microbiome-based therapeutics is enabled by terabytes of DNA sequencing data ...
Manufactured by:G3T Therapeutics based inMidlothian, VIRGINIA (USA)
All drugs targeting cardiovascular disease currently on the market work by lowering cholesterol levels. G3T identified and genetically validated an entirely novel biological mechanism and potential drug target that treats both cardiovascular disease, as well as non-alcoholic fatty liver disease. ...
Manufactured by:Bioneer Corporation based inDaedeok-gu, SOUTH KOREA
ExiStation™ is a workflow platform consisting of Max. 3 ExiPrep™ 16 Dx and one Exicycler™ 96. This unique composition allows simultaneous diagnosis of various diseases regardless of target and sample type. ExiStation™ is a pipetting-free system that mixes the extracted nucleic acids with the diagnostic reagents automatically, increasing ...
Manufactured by:DiagNodus Ltd. based inCambridge, UNITED KINGDOM
DiagNodus has designed and patented methods for non-invasive collection and analysis of samples indicative of the state of the human bowel. The technology is based upon disease biomarker detection. The approach addresses a range of diagnostic, screening and monitoring applications within the field of colorectal disease, in particular targeting ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
MolEQ designs novel compounds by optimizing multiple properties such as efficacy and toxicity of a lead ...